High Times Presents: The U.S. Cannabis Cup

sativex

Big Pharma Blocking Feds From Legalizing Marijuana?

While most of America is still struggling to legalize marijuana for medicinal purposes, a handful of large pharmaceutical companies are already generating a substantial amount of revenue from prescription drugs based on cannabis medicine. 

Cannabis Spray Only for the Rich?

For the past several months, HIGH TIMES has been providing extensive coverage on GW Pharmaceuticals’ popular cannabis-based drug called Sativex, which in addition to being recognized for years in some countries as a treatment option for multiple scler...

France Approves Cannabis-Based Medicine

Cannabis-based medicine will soon be available in France, as the country’s health officials recently approved commercial sales of the drug for the first time in history. A report from the Associated Press indicates that Britain’s GW Pharmaceuticals has been gr...

First Clinical Trial Conducted for Pot Cancer Treatment

A pharmaceutical company in the UK recently announced the completion of the first-recorded clinical trial to test the effects of cannabis-based medicine against cancer cells.

Notice

Important notice for Seattle US Cannabis Cup attendees.
A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.

This company is not affiliated with HIGH TIMES Magazine in any way. If you have purchased a travel package from High Times Travel LLC please contact HIGH TIMES immediately by emailing us at travelcomplaint@hightimes.com